The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility in Vivo

被引:715
|
作者
Huang, Xinglu [1 ]
Li, Linlin [1 ]
Liu, Tianlong [1 ]
Hao, Nanjing [1 ,2 ]
Liu, Huiyu [1 ]
Chen, Dong [1 ]
Tang, Fangqiong [1 ]
机构
[1] Chinese Acad Sci, Lab Controllable Preparat & Applicat Nanomat, Tech Inst Phys & Chem, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China
关键词
mesoporous silica nanoparticles (MSNs); shape; in vivo; biodistribution; clearance; biocompatibility; MESENCHYMAL STEM-CELLS; DRUG-DELIVERY; PARTICLE-SIZE; GOLD NANOPARTICLES; HEMOLYTIC-ACTIVITY; URINARY-EXCRETION; SURFACE-CHARGE; CANCER-THERAPY; QUANTUM DOTS; DESIGN;
D O I
10.1021/nn200365a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In our previous study we reported that the interaction of nanoparticles with cells can be influenced by particle shape, but until now the effect of particle shape on In vivo behavior remained poorly understood. In the present study, we control the fabrication of fluorescent mesoporous silica nanoparticles (MSNs) by varying the concentration of reaction reagents especially to design a series of shapes. Two different shaped fluorescent MSNs (aspect ratios, 1.5, 5) were specially designed, and the effects of particle shape on biodistribution, clearance and biocompatibility in vivo were investigated. Organ distributions show that intravenously administrated MSNs are mainly present in the liver, spleen and lung (>80%) and there is obvious particle shape effects on in vivo behaviors. Short-rod MSNs are easily trapped in the liver, while long-rod MSNs distribute in the spleen. MSNs with both aspect ratios have a higher content in the lung after PEG modification. We also found MSNs are mainly excreted by urine and feces, and the clearance rate of MSNs is primarily dependent on the particle shape, where short-rod MSNs have a more rapid clearance rate than long-rod MSNs in both excretion routes. Hematology, serum biochemistry, and histopathology results indicate that MSNs would not cause significant toxicity in vivo, but there is potential; Induction of binary excretion and glomerular filtration dysfunction. These findings may provide useful information for the design of nanoscale delivery systems and the environmental fate of nanoparticles.
引用
收藏
页码:5390 / 5399
页数:10
相关论文
共 50 条
  • [1] The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution
    Shao, Dan
    Lu, Meng-meng
    Zhao, Ya-wei
    Zhang, Fan
    Tan, Yong-fei
    Zheng, Xiao
    Pan, Yue
    Xiao, Xuan-ang
    Wang, Zheng
    Dong, Wen-fei
    Li, Jing
    Chen, Li
    ACTA BIOMATERIALIA, 2017, 49 : 531 - 540
  • [2] Biocompatibility of Mesoporous Silica Nanoparticles?
    Shi, Yi
    Miller, Michael L.
    Di Pasqua, Anthony J.
    COMMENTS ON INORGANIC CHEMISTRY, 2016, 36 (02) : 61 - 80
  • [3] Biocompatibility of Mesoporous Silica Nanoparticles
    Asefa, Tewodros
    Tao, Zhimin
    CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (11) : 2265 - 2284
  • [4] In Vivo Biodistribution, Clearance, and Biocompatibility of Multiple Carbon Dots Containing Nanoparticles for Biomedical Application
    Liao, Jinfeng
    Yao, Yuan
    Lee, Cheng-Hao
    Wu, Yongzhi
    Li, Pei
    PHARMACEUTICS, 2021, 13 (11)
  • [5] Time-dependent biodistribution, clearance and biocompatibility of magnetic fibrin nanoparticles: an in vivo study
    Prabu, Periyathambi
    Vedakumari, Weslen S.
    Sastry, Thotapalli P.
    NANOSCALE, 2015, 7 (21) : 9676 - 9685
  • [6] Advances in biocompatibility of mesoporous silica nanoparticles
    Gu, Jisheng
    Cai, Xiaobing
    Gongneng Cailiao/Journal of Functional Materials, 2015, 46 (18): : 18023 - 18026
  • [7] In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles
    Kumar, Rajiv
    Roy, Indrajit
    Ohulchanskky, Tymish Y.
    Vathy, Lisa A.
    Bergey, Earl J.
    Sajjad, Munawwar
    Prasad, Paras N.
    ACS NANO, 2010, 4 (02) : 699 - 708
  • [8] In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles
    Kumar, R.
    Roy, I
    Ohulchanskky, T. Y.
    NANOMEDICINE, 2010, 5 (05) : 688 - 689
  • [9] Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals
    Lu, Jie
    Liong, Monty
    Li, Zongxi
    Zink, Jeffrey I.
    Tamanoi, Fuyuhiko
    SMALL, 2010, 6 (16) : 1794 - 1805
  • [10] Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats
    Jain, Tapan K.
    Reddy, Maram K.
    Morales, Marco A.
    Leslie-Pelecky, Diandra L.
    Labhasetwar, Vinod
    MOLECULAR PHARMACEUTICS, 2008, 5 (02) : 316 - 327